MORNEAU MICHAEL

CIK 00015177802 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001517780

Recent Transactions

38 trades

Tax Payment
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2021-01-19$6.68/sh−1,685→ 116,062 total
Award
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2021-01-04+14,667→ 113,819 total
Award
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2021-01-04+6,667→ 120,486 total
Tax Payment
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2021-01-04$5.80/sh−2,739→ 117,747 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2021-01-04+33,000→ 33,000 total
Tax Payment
Viking Therapeutics, Inc.$VKTX
Common Stock
2020-09-15$6.25/sh−1,557→ 97,873 total
Award
Viking Therapeutics, Inc.$VKTX
Common Stock
2020-09-15+4,500→ 99,430 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2020-03-31+15,000→ 15,000 total
Tax Payment
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2020-01-19$7.18/sh−2,044→ 92,840 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2020-01-03+40,000→ 40,000 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2019-10-31+2,500→ 2,500 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2019-07-31+7,500→ 7,500 total
Tax Payment
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2019-01-19$8.78/sh−2,044→ 91,991 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2019-01-03+29,000→ 29,000 total
Sale
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2018-05-31$9.25/sh−21,551→ 94,035 total
Tax Payment
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2018-05-04$4.22/sh−7,616→ 94,035 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2018-01-19+52,500→ 52,500 total
Award
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2018-01-19+15,000→ 101,651 total
Tax Payment
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2017-05-04$1.34/sh−8,192→ 80,604 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2017-01-05+95,000→ 95,000 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2017-01-05+17,605→ 17,605 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2016-03-14+19,934→ 19,934 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2016-03-04+40,000→ 40,000 total
Award
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2015-05-04+67,000→ 67,000 total
Tax Payment
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2015-05-04$9.49/sh+10,404→ 77,404 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2015-05-04+25,500→ 25,500 total
Disposition to Issuer
Trius Therapeutics Inc
Common Stock
2013-09-11−14,070→ 0 total
Disposition to Issuer
Trius Therapeutics Inc
Stock Option (right to buy)
2013-09-11$9.50/sh−80,000→ 0 total
Disposition to Issuer
Trius Therapeutics Inc
Stock Option (right to buy)
2013-09-11$8.35/sh−15,000→ 0 total
Disposition to Issuer
Trius Therapeutics Inc
Stock Option (right to buy)
2013-09-11$7.37/sh−30,000→ 0 total
Sale
Trius Therapeutics Inc
Common Stock
2013-07-11$9.75/sh−20,000→ 12,545 total
Exercise/Conversion
Trius Therapeutics Inc
Common Stock
2013-07-11$4.00/sh+20,000→ 32,545 total
Exercise/Conversion
Trius Therapeutics Inc
Employee Stock Option (right to buy)
2013-07-11−20,000→ 80,000 total
Exercise/Conversion
Trius Therapeutics Inc
Common Stock
2013-05-14$4.00/sh+20,000→ 30,635 total
Exercise/Conversion
Trius Therapeutics Inc
Employee Stock Option (right to buy)
2013-05-14−20,000→ 0 total
Sale
Trius Therapeutics Inc
Common Stock
2013-05-14$7.75/sh−20,000→ 10,635 total
Award
Trius Therapeutics Inc
Stock Option (right to buy)
2013-03-07+30,000→ 30,000 total
Award
Trius Therapeutics Inc
Stock Option (right to buy)
2012-02-22+15,000→ 15,000 total

Companies

Recent Filings

Address

C/O TRIUS THERAPEUTICS, INC. 6310 NANCY RIDGE DRIVE, SUITE 101

SAN DIEGO, CA, 92121

View on SEC.gov